The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. The Modified Vaccinia Ankara (MVA) vector system is being explored as a platform for development of multiple vaccines. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkmann, Ariane, Williamson, Anna-Lise, Weidenthaler, Heinz, Meyer, Thomas P.H., Robertson, James S., Excler, Jean-Louis, Condit, Richard C., Evans, Eric, Smith, Emily R., Kim, Denny, Chen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568176/
https://www.ncbi.nlm.nih.gov/pubmed/33077299
http://dx.doi.org/10.1016/j.vaccine.2020.08.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568176/
https://www.ncbi.nlm.nih.gov/pubmed/33077299
http://dx.doi.org/10.1016/j.vaccine.2020.08.050

Ejemplares similares